Comparison of the different kinds of feeding on the level of fecal calprotectin

Early Human Development

Volumn 90, Issue 9, 2014, Pages 471-475

  Li, Feng ^a   Ma, Jingqiu ^a   Geng, Shanshan ^a   Wang, Junli ^a   Ren, Fang ^a   Sheng, Xiaoyang ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Breast feeding; Fecal calprotectin; Formula feeding; Infants

Indexed keywords

CALGRANULIN;

ARTICLE; ARTIFICIAL MILK; BODY HEIGHT; BODY WEIGHT; BREAST FEEDING; CHINA; COMPARATIVE STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; HUMAN; INFANT; INFANT FEEDING; MALE; QUESTIONNAIRE; CHEMISTRY; FECES; FEEDING BEHAVIOR;

BREAST FEEDING; FECES; FEEDING BEHAVIOR; FEMALE; HUMANS; INFANT; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; QUESTIONNAIRES;

EID: 84905243609     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2014.06.005     Document Type: Article

References (37)

1. Dale I., Brandtzaeg P., Fagerhol M.K., Scott H. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol 1985, 84:24-34.
2. Baldassarre M.E., Altomare M.A., Fanelli M., Carbone D., Di Bitonto G., Mautone A., et al. Does calprotectin represent a regulatory factor in host defense or a drug target in inflammatory disease?. Endocr Metab Immune Disord Drug Targets 2007, 7:1-5.
3. Chitkara D.K., Talley N.J., Schleck C., Zinsmeister A.R., Shah N.D., Locke G.R. Recollection of childhood abdominal pain in adults with functional gastrointestinal disorders. Scand J Gastroenterol 2009, 44:301-307.
4. Rasquin A., Di Lorenzo C., Forbes D., Guiraldes E., Hyams J.S., Staiano A., et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology 2006, 130:1527-1537.
5. Licata A., Randazzo C., Cappello M., Calvaruso V., Butera G., Florena A.M., et al. Fecal calprotectin in clinical practice: a noninvasive screening tool for patients with chronic diarrhea. J Clin Gastroenterol 2012, 46:504-508.
6. Diamanti A., Colistro F., Basso M.S., Papadatou B., Francalanci P., Bracci F., et al. Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases. Inflamm Bowel Dis 2008, 14:1229-1235.
7. Turner D., Leach S.T., Mack D., Uusoue K., McLernon R., Hyams J., et al. Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response. Gut 2010, 59:1207-1212.
8. Baldassarre M.E., Fanelli M., Lasorella M.L., Laneve A., Grosso R., Falcone M.R., et al. Fecal calprotectin (FC) in newborns: is it a predictive marker of gastrointestinal and/or allergic disease?. Immunopharmacol Immunotoxicol 2011, 33:220-223.
9. Abraham B.P., Kane S. Fecal markers: calprotectin and lactoferrin. Gastroenterol Clin North Am 2012, 41:483-495.
10. Logan R. Faecal calprotectin for the diagnosis of inflammatory bowel disease. BMJ 2010, 341:c3636.
11. Morisset M., Aubert-Jacquin C., Soulaines P., Moneret-Vautrin D.A., Dupont C. A non-hydrolyzed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy. Eur J Clin Nutr 2011, 65:175-183.
12. Kapel N., Campeotto F., Kalach N., Baldassare M., Butel M.J., Dupont C. Faecal calprotectin in term and preterm neonates. J Pediatr Gastroenterol Nutr 2010, 51:542-547.
13. Taylor S.N., Basile L.A., Ebeling M., Wagner C.L. Intestinal permeability in preterm infants by feeding type: mother's milk versus formula. Breastfeed Med 2009, 4:11-15.
14. Laforgia N., Baldassarre M.E., Pontrelli G., Indrio F., Altomare M.A., Di Bitonto G., et al. Calprotectin levels in meconium. Acta Paediatr 2003, 92:463-466.
15. Savino F., Castagno E., Calabrese R., Viola S., Oggero R., Miniero R. High faecal calprotectin levels in healthy, exclusively breast-fed infants. Neonatology 2010, 97:299-304.
16. Dorosko S.M., Mackenzie T., Connor R.I. Fecal calprotectin concentrations are higher in exclusively breastfed infants compared to those who are mixed-fed. Breastfeed Med 2008, 3:117-119.
17. Campeotto F., Butel M.J., Kalach N., Derrieux S., Aubert-Jacquin C., Barbot L., et al. High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed 2004, 89:F353-F355.
18. Rosti L., Braga M., Fulcieri C., Sammarco G., Manenti B., Costa E. Formula milk feeding does not increase the release of the inflammatory marker calprotectin, compared to human milk. Pediatr Med Chir 2011, 33:178-181.
19. Liu J.R., Sheng X.Y., Hu Y.Q., Yu X.Y., Westcott J., Miller L.V., et al. Fecal calprotectin levels are higher in rural than in urban Chinese infants and negatively associated with growth. BMC Pediatr 2012, 12:129.
20. Manz M., Burri E., Rothen C., Tchanguizi N., Niederberger C., Rossi L., et al. Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study. BMC Gastroenterol 2012, 12:5.
21. Rouge C., Butel M.J., Piloquet H., Ferraris L., Legrand A., Vodovar M., et al. Fecal calprotectin excretion in preterm infants during the neonatal period. PLoS One 2010, 5:e11083.
22. Hestvik E., Tumwine J.K., Tylleskar T., Grahnquist L., Ndeezi G., Kaddu-Mulindwa D.H., et al. Faecal calprotectin concentrations in apparently healthy children aged 0-12years in urban Kampala, Uganda: a community-based survey. BMC Pediatr 2011, 11:9.
23. Olafsdottir E., Aksnes L., Fluge G., Berstad A. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr 2002, 91:45-50.
24. Rugtveit J., Fagerhol M.K. Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr 2002, 34:323-324. [author reply 4-5].
25. Rhoads J.M., Fatheree N.Y., Norori J., Liu Y., Lucke J.F., Tyson J.E., et al. Altered fecal microflora and increased fecal calprotectin in infants with colic. J Pediatr 2009, 155:823-828. [e1].
26. Berstad A., Arslan G., Folvik G. Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid. Scand J Gastroenterol 2000, 35:64-69.
27. Catassi C., Bonucci A., Coppa G.V., Carlucci A., Giorgi P.L. Intestinal permeability changes during the first month: effect of natural versus artificial feeding. J Pediatr Gastroenterol Nutr 1995, 21:383-386.
28. Weaver L.T., Laker M.F., Nelson R., Lucas A. Milk feeding and changes in intestinal permeability and morphology in the newborn. J Pediatr Gastroenterol Nutr 1987, 6:351-358.
29. Wagner C.L., Taylor S.N., Johnson D. Host factors in amniotic fluid and breast milk that contribute to gut maturation. Clin Rev Allergy Immunol 2008, 34:191-204.
30. Moreau M.C., Gaboriau-Routhiau V. Influence of resident intestinal microflora on the development and functions of the gut-associated lymphoid tissue. Microb Ecol Health Dis 2001, 13:65-86.
31. Westerbeek E.A., Morch E., Lafeber H.N., Fetter W.P., Twisk J.W., Van Elburg R.M. Effect of neutral and acidic oligosaccharides on fecal IL-8 and fecal calprotectin in preterm infants. Pediatr Res 2011, 69:255-258.
32. Field C.J. The immunological components of human milk and their effect on immune development in infants. J Nutr 2005, 135:1-4.
33. Bode L. Recent advances on structure, metabolism, and function of human milk oligosaccharides. J Nutr 2006, 136:2127-2130.
34. Boehm G., Moro G. Structural and functional aspects of prebiotics used in infant nutrition. J Nutr 2008, 138:1818S-1828S.
35. Lu L., Walker W.A. Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am J Clin Nutr 2001, 73:1124S-1130S.
36. Nash S., Stafford J., Madara J.L. Effects of polymorphonuclear leukocyte transmigration on the barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1987, 80:1104-1113.
37. Steinbakk M., Naess-Andresen C.F., Lingaas E., Dale I., Brandtzaeg P., Fagerhol M.K. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990, 336:763-765.